The Effect of GCSF in the Treatment of ALS Patients

Phase 2/3 Completed 40 enrolled Tehran University of Medical Sciences

RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to evaluate the effect off Granulocyte Colony Stimulating Factor (GCSF) in the treatment of Amyotrophic Lateral Sclerosis (ALS) patients.

Timeline

Start: 2012-11
Primary completion: 2013-11
Completion: 2013-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Granulocyte colony-stimulating factor	Protein / enzyme biologic	10 ug/kg	Subcutaneous

The Effect of GCSF in the Treatment of ALS Patients

Summary

Timeline

Drugs

Indications